NCT00985868View on ClinicalTrials.gov

AT9283 in Children and Adolescents With Relapsed and Refractory Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

January 25, 2016

Study Completion Date

November 20, 2019

Conditions
Unspecified Childhood Solid Tumor, Protocol Specific
Interventions
DRUG

multikinase inhibitor AT9283

OTHER

enzyme-linked immunosorbent assay

OTHER

immunohistochemistry staining method

OTHER

laboratory biomarker analysis

OTHER

pharmacological study

Trial Locations (5)

B4 6NH

Birmingham Children's Hospital, Birmingham

LS9 7TF

Leeds General Infirmary, Leeds

M27 4HA

Royal Manchester Children's Hospital, Manchester

NE1 4LP

Great North Children's Hospital, Royal Victoria Infirmary, Newcastle upon Tyne

SM2 5PT

Royal Marsden - Surrey, Sutton

Sponsors

Lead Sponsor

Cancer Research UK
All Listed Sponsors
lead

Cancer Research UK

OTHER

NCT00985868 - AT9283 in Children and Adolescents With Relapsed and Refractory Solid Tumors | Biotech Hunter | Biotech Hunter